MD Anderson Helps Pfizer, J&J Play Catch-up In Cancer Immunotherapy
This article was originally published in The Pink Sheet Daily
Executive Summary
MD Anderson Cancer Center has signed research collaborations with the two big pharmas as part of a broader effort to develop novel cancer immunotherapies or combinations.